These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 17691773)

  • 41. Fevipiprant (QAW039), a Slowly Dissociating CRTh2 Antagonist with the Potential for Improved Clinical Efficacy.
    Sykes DA; Bradley ME; Riddy DM; Willard E; Reilly J; Miah A; Bauer C; Watson SJ; Sandham DA; Dubois G; Charlton SJ
    Mol Pharmacol; 2016 May; 89(5):593-605. PubMed ID: 26916831
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Targeting the PGD
    Kupczyk M; Kuna P
    Drugs; 2017 Aug; 77(12):1281-1294. PubMed ID: 28612233
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dynamic behavior of fully solvated beta2-adrenergic receptor, embedded in the membrane with bound agonist or antagonist.
    Spijker P; Vaidehi N; Freddolino PL; Hilbers PA; Goddard WA
    Proc Natl Acad Sci U S A; 2006 Mar; 103(13):4882-7. PubMed ID: 16551744
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A novel biological role for prostaglandin D2 is suggested by distribution studies of the rat DP prostanoid receptor.
    Wright DH; Nantel F; Metters KM; Ford-Hutchinson AW
    Eur J Pharmacol; 1999 Jul; 377(1):101-15. PubMed ID: 10448933
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prostanoid receptors involved in regulation of the beating rate of neonatal rat cardiomyocytes.
    Mechiche H; Grassin-Delyle S; Robinet A; Nazeyrollas P; Devillier P
    PLoS One; 2012; 7(9):e45273. PubMed ID: 22984630
    [TBL] [Abstract][Full Text] [Related]  

  • 46. D-type prostanoid receptor enhances the signaling of chemoattractant receptor-homologous molecule expressed on T(H)2 cells.
    Sedej M; Schröder R; Bell K; Platzer W; Vukoja A; Kostenis E; Heinemann A; Waldhoer M
    J Allergy Clin Immunol; 2012 Feb; 129(2):492-500, 500.e1-9. PubMed ID: 21930295
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Different effects of spinally applied prostaglandin D2 on responses of dorsal horn neurons with knee input in normal rats and in rats with acute knee inflammation.
    Telleria-Diaz A; Ebersberger A; Vasquez E; Schache F; Kahlenbach J; Schaible HG
    Neuroscience; 2008 Sep; 156(1):184-92. PubMed ID: 18678231
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular cloning and characterization of the human prostanoid DP receptor.
    Boie Y; Sawyer N; Slipetz DM; Metters KM; Abramovitz M
    J Biol Chem; 1995 Aug; 270(32):18910-6. PubMed ID: 7642548
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Optimization of phenylacetic acid derivatives for CRTH2 and DP selective antagonism.
    Wang Y; Fu Z; Schmitt M; Wang X; Shen W; Rickel E; Martin T; Budelsky A; Marshall D; Collins T; Tang HL; Medina JC; Liu JJ
    Bioorg Med Chem Lett; 2012 Jan; 22(1):367-70. PubMed ID: 22119474
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The second PGD(2) receptor CRTH2: structure, properties, and functions in leukocytes.
    Nagata K; Hirai H
    Prostaglandins Leukot Essent Fatty Acids; 2003; 69(2-3):169-77. PubMed ID: 12895600
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation.
    Meja KK; Barnes PJ; Giembycz MA
    Br J Pharmacol; 1997 Sep; 122(1):149-57. PubMed ID: 9298541
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CRTH2 is not involved in the anti-enteropooling effect of PGD2 in the small intestine.
    Prenn C; Heinemann A; Schuligoi R; Peskar BA
    Pharmacology; 2008; 81(3):236-40. PubMed ID: 18212515
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells.
    Kiriyama M; Ushikubi F; Kobayashi T; Hirata M; Sugimoto Y; Narumiya S
    Br J Pharmacol; 1997 Sep; 122(2):217-24. PubMed ID: 9313928
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The endogenous bioactive lipid prostaglandin D
    Alhouayek M; Buisseret B; Paquot A; Guillemot-Legris O; Muccioli GG
    FASEB J; 2018 Sep; 32(9):5000-5011. PubMed ID: 29630407
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of the prostaglandin D2 receptor, DP, in eosinophil trafficking.
    Schratl P; Royer JF; Kostenis E; Ulven T; Sturm EM; Waldhoer M; Hoefler G; Schuligoi R; Lippe IT; Peskar BA; Heinemann A
    J Immunol; 2007 Oct; 179(7):4792-9. PubMed ID: 17878378
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prostaglandin D(2) induces apoptosis of human osteoclasts through ERK1/2 and Akt signaling pathways.
    Yue L; Haroun S; Parent JL; de Brum-Fernandes AJ
    Bone; 2014 Mar; 60():112-21. PubMed ID: 24345643
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Activation Mechanism of Prostanoid Receptors -X-ray Crystallography of EP3 Receptor].
    Morimoto K
    Yakugaku Zasshi; 2021; 141(4):473-479. PubMed ID: 33790113
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Piglet saphenous vein contains multiple relaxatory prostanoid receptors: evidence for EP4, EP2, DP and IP receptor subtypes.
    Wilson RJ; Giles H
    Br J Pharmacol; 2005 Feb; 144(3):405-15. PubMed ID: 15655509
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prostaglandin D2 inhibits collagen secretion from lung fibroblasts by activating the DP receptor.
    Ayabe S; Kida T; Hori M; Ozaki H; Murata T
    J Pharmacol Sci; 2013; 121(4):312-7. PubMed ID: 23538675
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression and molecular pharmacology of the mouse CRTH2 receptor.
    Hata AN; Zent R; Breyer MD; Breyer RM
    J Pharmacol Exp Ther; 2003 Aug; 306(2):463-70. PubMed ID: 12721327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.